Fair Value Measurements (Tables)

12 Months Ended

Jun. 30, 2015

Jun. 30, 2014

Fair Value Disclosures [Abstract]

Fair Value Inputs, Liabilities, Quantitative Information [Table Text Block]

Unobservable Input	ClinIntel Range
Discount rate	4%
Probability of achieving financial targets	100%
Projected period of payment	August 2016

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

(in thousands)	Fair Value
Balance at June 30, 2013	$	5,934
Change in fair value related to contingent consideration from HERON acquisition	(782		)
Balance at June 30, 2014	$	5,152
Additions of contingent consideration from ClinIntel acquisition	9,882
Change in fair value of contingent consideration	(7,421		)
Effect of changes in exchange rates used for translation	(322		)
Balance at June 30, 2015	$	7,291

Fair Value Hierarchy By Level

(in thousands)	Level 1		Level 2			Level 3			Total
Contingent Consideration	$	—	$	—		$	(7,291	)	$	(7,291	)
Interest Rate Derivative Instruments	—		719			—			719
Foreign Currency Exchange Contracts	—		(5,612		)	—			(5,612		)
Total	$	—	$	(4,893	)	$	(7,291	)	$	(12,184	)

(in thousands)	Level 1		Level 2		Level 3			Total
Contingent Consideration	$	—	$	—	$	(5,152	)	$	(5,152	)
Interest Rate Derivative Instruments	—		580		—			580
Foreign Currency Exchange Contracts	—		6,463		—			6,463
Total	$	—	$	7,043	$	(5,152	)	$	1,891